We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Tests for Syphilis Are Convenient and Reliable

By HospiMedica staff writers
Posted on 09 Oct 2006
Two new convenient tests, used in combination, provide reliable diagnosis of syphilis infection.

The causative organism of syphilis is Treponema pallidum, a spirochete which cannot be grown on culture media or in tissue culture. More...
The infection is normally diagnosed by the detection of antibody specific for T pallidum in the patient's blood or cerebrospinal fluid (CSF). Detection of the antibody becomes possible three to four weeks after infection. Two groups of antibodies are formed in response to infection: reagin antibodies that are present in active disease, and specific T pallidum antibodies, which persist long after the infection has been successfully treated.

The Oxoid (Basingstoke, UK) diagnostic reagent venereal diseases research laboratory (VDRL) carbon antigen test is a rapid agglutination test that detects reagin antibodies in serum or plasma in just eight minutes. The Oxoid T pallidum hemagglutination assay (TPHA) test is a sensitive passive hemagglutination test that detects specific T pallidum antibodies in serum within one hour. Used in combination, these assays provide laboratories with inexpensive, easy-to-perform, and rapid tools for the diagnosis of syphilis. No specialized equipment is required and results are clearly visible and easily interpreted.

According to the Health Protection Agency in London (HPA, UK), the number of sexually transmitted infections in the UK has continued to increase, rising by 3% from 2004-2005. The biggest increase was seen in the number of new cases of syphilis, which rose by 23% to 2,807 cases in 2005. Therefore, laboratories need accurate and reliable diagnostic methods that are easily accessible and cost effective.

Sexual infection diagnoses have been almost continually rising since the 1990s, with the highest increases in recent years occurring in the 16-24 age group. Professor Peter Borriello, director of the HPA's center for infections, said that the figures contained "mixed news” with the fall in gonorrhea showing that real progress was being made. "However, it is disappointing to see that there was a further rise in new diagnoses of sexually transmitted diseases (STIs) and these figures show there is still much to be done to tackle the continuing spread of infection.” He added that some of the rise could be accounted for by the better testing arrangements that have been introduced by sexual health clinics.



Related Links:
Oxoid

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.